Kelly Roehl

TL;DR: Traditional screening and assessment tools did not uniformly identify patients as malnourished or at nutrition risk in the ICU and therefore may be inappropriate for use in this population.

TL;DR: With the vast number of products available, rising costs of healthcare, and the drive toward evidence-based practice, it is imperative that clinicians carefully consider research regarding use of specialty formulas, paying close attention to the quality, patient population, clinical end points, and cost.

TL;DR: Modified ketogenic diet therapies reduce seizure frequency and severity and improve QOL among adults with DRE with few side effects outside of weight loss, a desired outcome among many adults with drug-resistant epilepsy.

TL;DR: KDTs may be safe and effective in treating adults with drug-resistant epilepsy and there is emerging evidence supporting the use in other adult neurologic disorders and general medical conditions as well.

TL;DR: It is found that among variables available at PN initiation, DM diagnosis, A1c ≥5.7% (P < .001), BG >120 mg/dL on PN start day, and ICU admission predicted the need for PN insulin.